Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Merker

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Plos One|August 5, 2022
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in EthiopiaEyob Abera Mesfin, Matthias Merker, Dereje Beyene, et al.
Diagnostic Microbiology and Infectious Disease|February 9, 2019
Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosisJuliane Havlicek, Beatrice Dachsel, Peter Slickers, et al.
Journal of Clinical Microbiology|December 8, 2017
Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single CartridgeJuliane Havlicek, Beatrice Dachsel, Peter Slickers, et al.
Journal of Clinical Microbiology|May 3, 2014
Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approachThomas A Kohl, Roland Diel, Dag Harmsen, et al.
Plos Pathogens|September 30, 2020
Insertion and deletion evolution reflects antibiotics selection pressure in a Mycobacterium tuberculosis outbreakMaxime Godfroid, Tal Dagan, Matthias Merker, et al.
Emerging Infectious Diseases|February 22, 2019
Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, SerbiaIrena Arandjelović, Matthias Merker, Elvira Richter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2019
Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis TreatmentSilke Polsfuss, Sabine Hofmann-Thiel, Matthias Merker, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Use of Whole Genome Sequencing for Mycobacterium tuberculosis Complex Antimicrobial Susceptibility TestingVanessa Mohr, Lindsay Sonnenkalb, Christian Utpatel, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Use of Whole Genome Sequencing for Mycobacterium tuberculosis Complex Antimicrobial Susceptibility Testing: From Sequence Data to Resistance ProfilesViola Dreyer, Lindsay Sonnenkalb, Margo Diricks, et al.
Genes|March 25, 2022
Molecular Epidemiology of <i>Mycobacterium tuberculosis</i> Complex Strains in Urban and Slum Settings of Nairobi, KenyaGlennah Kerubo, Perpetua Ndungu, Yassir Adam Shuaib, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Plos One|August 5, 2022
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in EthiopiaEyob Abera Mesfin, Matthias Merker, Dereje Beyene, et al.
Diagnostic Microbiology and Infectious Disease|February 9, 2019
Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosisJuliane Havlicek, Beatrice Dachsel, Peter Slickers, et al.
Journal of Clinical Microbiology|December 8, 2017
Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single CartridgeJuliane Havlicek, Beatrice Dachsel, Peter Slickers, et al.
Journal of Clinical Microbiology|May 3, 2014
Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approachThomas A Kohl, Roland Diel, Dag Harmsen, et al.
Plos Pathogens|September 30, 2020
Insertion and deletion evolution reflects antibiotics selection pressure in a Mycobacterium tuberculosis outbreakMaxime Godfroid, Tal Dagan, Matthias Merker, et al.
Emerging Infectious Diseases|February 22, 2019
Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, SerbiaIrena Arandjelović, Matthias Merker, Elvira Richter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2019
Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis TreatmentSilke Polsfuss, Sabine Hofmann-Thiel, Matthias Merker, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Use of Whole Genome Sequencing for Mycobacterium tuberculosis Complex Antimicrobial Susceptibility TestingVanessa Mohr, Lindsay Sonnenkalb, Christian Utpatel, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Use of Whole Genome Sequencing for Mycobacterium tuberculosis Complex Antimicrobial Susceptibility Testing: From Sequence Data to Resistance ProfilesViola Dreyer, Lindsay Sonnenkalb, Margo Diricks, et al.
Genes|March 25, 2022
Molecular Epidemiology of <i>Mycobacterium tuberculosis</i> Complex Strains in Urban and Slum Settings of Nairobi, KenyaGlennah Kerubo, Perpetua Ndungu, Yassir Adam Shuaib, et al.
Pageof 9